Prasobh Jacob

Prasobh Jacob

Auto-generated profile, based on publicly available information

Prasobh Jacob

Prasobh Jacob, MSc, ACSM-CEP, AACVPR-CCRP, Physiotherapy Specialist, Cardiac Rehabilitation Department, Heart Hospital, Hamad Medical Corporation, Doha, Qatar

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2023 in BMJ Open Quality
Verified
Journal Article
Open access
PDF file
JDJavier Loureiro Diaz
Javier Loureiro Diaz
LFLiam David Foster
Liam David Foster
PSPraveen Jayaprabha Surendran
Praveen Jayaprabha Surendran
PJPrasobh Jacob
Prasobh Jacob
OIOmar Ibrahim
Omar Ibrahim
PGPoonam Gupta
Poonam Gupta
The COVID-19 pandemic resulted in the cessation of approximately 75% of cardiac rehabilitation (CR) programmes worldwide. In March 2020, CR phase II (CRP2) services were stopped in Qatar. Multiple studies had shown safety, effectiveness, reduced cost of delivery and improved participation with hybrid CR. A multidisciplinary team reviewed various alternative models for delivery and decided to implement a hybrid CRP2 exercise programme (HCRP2-EP) to ensure continuation of our patient care. Our aim was to enrol in the HCRP2-EP 70% of all eligible patients by 30 September 2020. Institute for Health Care Improvement’s collaborative model was adopted. Multiple plan–do–study–act cycles were used to test change ideas. The outcomes of the project were analysed using standard run chart rules to detect the changes in outcomes over time. This project was implemented from March 2020, and the male patients enrolled between August 2020 and April 2021, with sustained monthly median enrolment above target of 70% throughout. As for our secondary outcome, 75.8% of the male patients who completed HCRP2-EP showed a meaningful change in peak exercise capacity of ≥10% (mean change 17%±6%). There were no major adverse events reported, and the median Patient Satisfaction Score was 96% well above the institutional target of 90%. This shows a well-designed quality improvement programme is an appropriate strategy for implementing HCRP2-EP in a clinical setting, and HCRP2-EP is a feasible, effective and safe intervention in eligible male patients with cardiovascular disease.

6 November 2023 in BMJ Open Quality
Verified
Journal Article
Open access
PDF file
PJPrasobh Jacob
Prasobh Jacob
PSPraveen Jayaprabha Surendran
Praveen Jayaprabha Surendran
PGPoonam Gupta
Poonam Gupta
MMMenandro Mahinay
Menandro Mahinay
ASAnsel Lakindanum Sarmiento
Ansel Lakindanum Sarmiento
RSRajvir Singh
Rajvir Singh
Early mobility and activity programmes following cardiac surgery are vital for improved patient outcomes, as they accelerate the recovery of functional capacity and walking distance. We observed that only 5.3% of our patients achieved a Functional Independence Measurement (FIM) score of 80% or more by the third postoperative day (POD). Additionally, the average 6-minute walk distance achieved by the fourth POD was only 188 m. Therefore, a quality improvement (QI) project was implemented with the aim of attaining a FIM score of 80% by the third POD for more than 80% of patient underwent/undergoing cardiac surgery without complications. A model-for-improvement framework was used to drive continuous improvement. This project was implemented in February 2021. Baseline data were prospectively collected between November 2020 and January 2021 (preintervention). Outcomes were analysed using standard control chart rules to detect changes over time. Unpaired Student t-tests assessed significant differences in mean levels between two groups, (preintervention vs postintervention).χ2 tests were conducted between the two groups according to gender and patient satisfaction scores. The percentage of patients who achieved a FIM score of 80% or more by the third POD gradually increased to 91.4% 5 months following programme implementation and was sustained thereafter. The mean patient FIM score significantly improved to 81.20±3.77 (p<0.001) by the third POD. Similarly, the mean 6-minute walk distance increased to 267.90±36.10 m (p<0.001) by the fourth POD. The percentage of patients who displayed the level of confidence needed to carry out activities of daily living (ADL) and exercises independently at home increased to 89.4% (p<0.001) by the fifth POD. No adverse events associated with the mobility and activity programme were reported. This QI project demonstrated a substantial improvement in patient functional independence, walking distance and the level of confidence needed to independently carry out ADL and exercises following cardiac surgery.

24 September 2024 in Libyan Journal of Medicine
Verified
Journal Article
Open access
JDJavier Loureiro Diaz
Javier Loureiro Diaz
PSPraveen Jayaprabha Surendran
Praveen Jayaprabha Surendran
AGAmine Ghram
Amine Ghram
PJPrasobh Jacob
Prasobh Jacob
LFLiam David Foster
Liam David Foster
MAMohammed Abdulla A. A. Al-Hashemi
Mohammed Abdulla A. A. Al-Hashemi
Cardiac rehabilitation (CR) significantly improves cardiovascular outcomes in patients with coronary artery disease (CAD). International guidelines vary in the minimum recommended frequency of supervised exercise from 1 to 3 sessions per week. This is the first study in the Middle East and North African regions assessing the impact of 2 versus 3 days/week of supervised exercise on peak exercise capacity in patients with CAD. Single-center retrospective cohort study involving 362 patients enrolled in the only CR center in the State of Qatar. Only high-quality data was included by strict evaluation of compliance to the exercise intervention. Fifty patients who underwent a symptom-limited exercise test before and after CR were included (31 patients on 2 days/week, 19 on 3 days/week). No significant differences were observed in baseline characteristics between groups. Exercise intervention differed significantly between groups in exercise training frequency (2 days/week: 1.97 ± 0.2 vs. 3 days/week: 2.7 ± 0.3; p < 0.00). Peak exercise capacity as peak metabolic equivalents of task (MET) significantly increased in both groups (2 days/week: Pre 8.3 ± 2.4 vs. Post 9.4 ± 2.9, p-value 0.00; 3 days/week: Pre 7.4 ± 1.6 vs. Post 8.4 ± 2.0, p-value 0.00). No significant difference was observed between groups for change in Peak Exercise Capacity (2 days/week 1.1 ± 1.1 vs. 3 days/week 1.0 ± 0.9, p = 0.87). When the total number of exercise sessions is equal, supervised exercise frequencies of 2 and 3 days/week may significantly and equally improve peak exercise capacity in patients with CAD.

9 March 2025 in CJC Open
Verified
Journal Article
Open access
JDJavier Loureiro Diaz
Javier Loureiro Diaz
PJPrasobh Jacob
Prasobh Jacob
PSPraveen Jayaprabha Surendran
Praveen Jayaprabha Surendran
OIOmar Ibrahim
Omar Ibrahim

17 February 2026 in Journal of Cardiovascular Nursing
Verified
Journal Article
Closed access
JDJavier Loureiro Diaz
Javier Loureiro Diaz
AGAmine Ghram
Amine Ghram
PSPraveen Jayaprabha Surendran
Praveen Jayaprabha Surendran
PJPrasobh Jacob
Prasobh Jacob
SCSalma Chbib
Salma Chbib
MAMohammed Alhashemi
Mohammed Alhashemi
Background: Silent myocardial ischemia (SMI) predicts adverse outcomes in coronary artery disease, yet the effects of cardiac rehabilitation (CR) in this group are limited. We evaluated the impact of CR on peak exercise capacity, ischemic threshold, training workload progression, medication adherence, depression, and exercise-related adverse events in patients with documented SMI Type I and II. Methods: This retrospective cohort study includes 966 patients referred to CR. Twenty-nine patients who completed ≥1 session and had valid pre and post exercise tests were included in the final analysis. Main outcomes were changes in peak exercise capacity and ischemic threshold. Rate of adverse events, medication compliance, adverse drug reactions, and cardiac depression scores were also evaluated. Paired t tests were used (α=0.05). Results: Exercise-based CR resulted in a clinically and statistically significant improvement in exercise capacity (MET peak : 8.43 ± 2.51 to 9.14 ± 2.81, P < .001). At ischemic threshold, heart rate increased (123.94 ± 16.08 to 127.82 ± 17.23, P < .001), systolic blood pressure reduced (167.41 ± 33.14 to 164.41 ± 22.59, P = .006), and rate-pressure product increased (21939.53 ± 5362.54 to 22013.88 ± 4203.48, P = .009). The rate of exercise-related adverse events was low (2.23 per 100 sessions), with no major adverse events. Compliance with medications remained above 85% pre-to-post CR, with only 1 reported adverse drug reaction. Conclusions: Exercise-based CR is safe and effective for patients with SMI, improving exercise capacity and ischemic tolerance with few adverse events. These findings support integrating CR into the management of asymptomatic, high-risk coronary patients.

16 October 2025 in Clinical Case Reports
Verified
Journal Article
Open access
JDJavier Loureiro Diaz
Javier Loureiro Diaz
PSPraveen Jayaprabha Surendran
Praveen Jayaprabha Surendran
PJPrasobh Jacob
Prasobh Jacob
SCSalma Chbib
Salma Chbib
AGAmine Ghram
Amine Ghram
OIOmar Ibrahim
Omar Ibrahim
Heart failure with reduced ejection fraction leads to exercise intolerance due to central and peripheral dysfunction. Improvements in exercise performance are not fully captured by traditional measures like peak oxygen consumption alone. A 57‐year‐old male with a complex cardiac medical history of hypertrophic cardiomyopathy with left ventricle non‐compaction, Wolff‐Parkinson‐White syndrome, transient ischemic stroke, and heart failure with reduced ejection fraction with an implanted cardiac resynchronization therapy defibrillator underwent cardiac rehabilitation. Cardiopulmonary exercise testing revealed a non‐proportional improvement in peak oxygen consumption (0.3 METs, 9%) versus peak workload (48 W, 61%). Gross mechanical economy and efficiency improved at all physiological thresholds: at ventilatory threshold by 11%, at respiratory compensation point by 60% and 41%, and at peak oxygen consumption by 47% and 33%, respectively. Mechanical economy and mechanical efficiency should be measured and reported for assessing rehabilitation outcomes in heart failure with reduced ejection fraction.